Life Science Software Market Latest Technologies Research And Future Scope By 2033 | |
The Life Science Software Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033). Learn More On The Life Science Software Market: https://www.thebusinessresearchcompany.com/report/life-science-software-global-market-report According to The Business Research Company’s Life Science Software Global Market Report 2024, The life science software market size has grown rapidly in recent years. It will grow from $19.45 billion in 2024 to $22.31 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to regulatory compliance requirements, data integration and management needs, rising demand for personalized medicine, globalization of clinical trials, patient-centric approaches. Get A Free Sample Of The Report (Includes Graphs And Tables): https://www.thebusinessresearchcompany.com/sample.aspx?id=13690&type=smp The life science software market covered in this report is segmented – 1) By Type: Predictive, Descriptive, Prescriptive 2) By Deployment: On-Premise, Hosted 3) By Application : Marketing, Compliance, R&D, Pharmacovigilance, SCM 4) By End User: Healthcare Institutes, Biopharmaceutical Industry, Medical Devices Industry, Medical Research Centers Major companies operating in the life science software market are integrating advanced technologies,, such as generative AI, machine learning (ML) and computer-aided drug-design (CADD), for improving drug discovery process, enhancing efficiency and accelerating breakthroughs. Generative AI is employed to design novel molecular structures, while ML algorithms analyze vast datasets to identify potential drug candidates and predict their efficacy. Integrated with CADD tools, these technologies enable researchers to computationally simulate and optimize drug interactions, significantly streamlining the identification and development of promising compounds. For instance, in December 2024, Merck, a Germany-based science and technology company, launched AIDDISON, a drug discovery software. AIDDISON is intended to speed the identification of novel medications and increase the efficiency of the drug development process. The platform is based on artificial intelligence (AI) and machine learning (ML) technologies, allowing it to evaluate massive volumes of data and find prospective medication candidates faster and more effectively than traditional approaches. The life science software market report table of contents includes: 1. Executive Summary 2. Life Science Software Market Characteristics 3. Life Science Software Market Trends And Strategies 4. Life Science Software Market - Macro Economic Scenario 5. Global Life Science Software Market Size and Growth ...... 32. Global Life Science Software Market Competitive Benchmarking 33. Global Life Science Software Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Life Science Software Market 35. Life Science Software Market Future Outlook and Potential Analysis 36. Appendix | |
| Target State: All States Target City : All Cities Last Update : Mar 21, 2024 6:52 AM Number of Views: 28 | Item Owner : TBRC Contact Email: (None) Contact Phone: (None) |
| Friendly reminder: Click here to read some tips. | |